bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
alfaxan multidose 10 mg/ml injektioneste, liuos
jurox (ireland) limited - alfaxalone - injektioneste, liuos - 10 mg/ml - alfaksaloni
alfaxan 10 mg/ml injektioneste, liuos
jurox (ireland) limited - alfaxalone - injektioneste, liuos - 10 mg/ml - alfaksaloni
fipralone vet. 67 mg paikallisvaleluliuos
alfamed - fipronil - paikallisvaleluliuos - 67 mg - fiproniili
fipralone vet. 134 mg paikallisvaleluliuos
alfamed - fipronil - paikallisvaleluliuos - 134 mg - fiproniili
fipralone vet. 268 mg paikallisvaleluliuos
alfamed - fipronil - paikallisvaleluliuos - 268 mg - fiproniili
fipralone vet. 402 mg paikallisvaleluliuos
alfamed - fipronil - paikallisvaleluliuos - 402 mg - fiproniili
alea 20 mg / 5 mg tabletti, kalvopäällysteinen
menarini international operations luxembourg s.a. - olmesartani medoxomilas,amlodipini besilas - tabletti, kalvopäällysteinen - 20 mg / 5 mg - olmesartaanimedoksomiili ja amlodipiini
alea 40 mg / 5 mg tabletti, kalvopäällysteinen
menarini international operations luxembourg s.a. - amlodipini besilas,olmesartani medoxomilas - tabletti, kalvopäällysteinen - 40 mg / 5 mg - olmesartaanimedoksomiili ja amlodipiini